171 related articles for article (PubMed ID: 34502550)
1. In Silico Screening of Novel α1-GABA
Zheng X; Wang C; Zhai N; Luo X; Liu G; Ju X
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502550
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Novel Xanthine Oxidase Inhibitors Based on 1,6-Dihydropyrimidine-5-Carboxylic Acids by an Integrated in Silico Study.
Zhai N; Wang C; Wu F; Xiong L; Luo X; Ju X; Liu G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360886
[TBL] [Abstract][Full Text] [Related]
3. Development of 1,3-thiazole analogues of imidazopyridines as potent positive allosteric modulators of GABA
Tikhonova TA; Rassokhina IV; Kondrakhin EA; Fedosov MA; Bukanova JV; Rossokhin AV; Sharonova IN; Kovalev GI; Zavarzin IV; Volkova YA
Bioorg Chem; 2020 Jan; 94():103334. PubMed ID: 31711764
[TBL] [Abstract][Full Text] [Related]
4. Design of novel dopamine D
Zhang C; Li Q; Meng L; Ren Y
J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
Hui WQ; Cheng Q; Liu TY; Ouyang Q
J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
[TBL] [Abstract][Full Text] [Related]
6. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
7. Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5.
Vijaya Prabhu S; Singh SK
J Recept Signal Transduct Res; 2018 Jun; 38(3):225-239. PubMed ID: 29806525
[TBL] [Abstract][Full Text] [Related]
8. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
[TBL] [Abstract][Full Text] [Related]
9. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
[TBL] [Abstract][Full Text] [Related]
10. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation.
Kumbhar N; Nimal S; Barale S; Kamble S; Bavi R; Sonawane K; Gacche R
Sci Rep; 2022 Feb; 12(1):1712. PubMed ID: 35110603
[TBL] [Abstract][Full Text] [Related]
13. Development of Novel Therapeutics for Schizophrenia Treatment Based on a Selective Positive Allosteric Modulation of α1-Containing GABAARs-In Silico Approach.
Đorđević V; Petković M; Živković J; Nikolić GM; Veselinović AM
Curr Issues Mol Biol; 2022 Jul; 44(8):3398-3412. PubMed ID: 36005130
[TBL] [Abstract][Full Text] [Related]
14. Orthosteric and benzodiazepine cavities of the α
Amundarain MJ; Viso JF; Zamarreño F; Giorgetti A; Costabel M
J Biomol Struct Dyn; 2019 Apr; 37(6):1597-1615. PubMed ID: 29633901
[TBL] [Abstract][Full Text] [Related]
15. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.
Zhang J; Hao QQ; Liu X; Jing Z; Jia WQ; Wang SQ; Xu WR; Cheng XC; Wang RL
Oncotarget; 2017 Apr; 8(15):25612-25627. PubMed ID: 28445965
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
Azam MA; Thathan J
SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
[TBL] [Abstract][Full Text] [Related]
18. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
19. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
Marondedze EF; Govender KK; Govender PP
J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
[TBL] [Abstract][Full Text] [Related]
20. Exploration of
Zhao Y; Yang H; Wu F; Luo X; Sun Q; Feng W; Ju X; Liu G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
